Solubilization techniques used for poorly water-soluble drugs

IF 14.7 1区 医学 Q1 PHARMACOLOGY & PHARMACY
Bing Xie, Yaping Liu, Xiaotong Li, Pei Yang, Wei He
{"title":"Solubilization techniques used for poorly water-soluble drugs","authors":"Bing Xie, Yaping Liu, Xiaotong Li, Pei Yang, Wei He","doi":"10.1016/j.apsb.2024.08.027","DOIUrl":null,"url":null,"abstract":"Currently, about 40% of approved drugs and nearly 90% of drug candidates are poorly water-soluble drugs. Low solubility reduces the likelihood that these drugs can be effectively used clinically. Effectively improving the solubility and bioavailability of poorly water-soluble drugs is a critical issue that needs to be urgently addressed in drug development and application. This review briefly introduces the conventional solubilization techniques such as solubilizers, hydrotropes, cosolvents, prodrugs, salt modification, micronization, cyclodextrin inclusion, solid dispersions, and details the crystallization strategies, ionic liquids, and polymer-based, lipid-based, and inorganic-based carriers in improving solubility and bioavailability. Some of the most commonly used approved carrier materials for solubilization techniques are presented, and some approved poorly water-soluble drugs using solubilization techniques are summarized. Furthermore, this review describes in detail the solubilization mechanism of each solubilization technique, reviews the latest research advances and challenges, and evaluates the potential for clinical translation. This review could guide the selection of a solubilization approach, dosage form, and administration route for poorly water-soluble drugs. Moreover, we discuss several promising solubilization techniques attracting increasing attention worldwide.","PeriodicalId":6906,"journal":{"name":"Acta Pharmaceutica Sinica. B","volume":"7 1","pages":""},"PeriodicalIF":14.7000,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Pharmaceutica Sinica. B","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1016/j.apsb.2024.08.027","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Currently, about 40% of approved drugs and nearly 90% of drug candidates are poorly water-soluble drugs. Low solubility reduces the likelihood that these drugs can be effectively used clinically. Effectively improving the solubility and bioavailability of poorly water-soluble drugs is a critical issue that needs to be urgently addressed in drug development and application. This review briefly introduces the conventional solubilization techniques such as solubilizers, hydrotropes, cosolvents, prodrugs, salt modification, micronization, cyclodextrin inclusion, solid dispersions, and details the crystallization strategies, ionic liquids, and polymer-based, lipid-based, and inorganic-based carriers in improving solubility and bioavailability. Some of the most commonly used approved carrier materials for solubilization techniques are presented, and some approved poorly water-soluble drugs using solubilization techniques are summarized. Furthermore, this review describes in detail the solubilization mechanism of each solubilization technique, reviews the latest research advances and challenges, and evaluates the potential for clinical translation. This review could guide the selection of a solubilization approach, dosage form, and administration route for poorly water-soluble drugs. Moreover, we discuss several promising solubilization techniques attracting increasing attention worldwide.
用于水溶性差药物的增溶技术
目前,约 40% 的已批准药物和近 90% 的候选药物都是水溶性较差的药物。低溶解度降低了这些药物在临床上有效使用的可能性。有效提高水溶性差药物的溶解度和生物利用度是药物开发和应用中急需解决的关键问题。本综述简要介绍了常规增溶技术,如增溶剂、水合助剂、助溶剂、原药、盐改性、微粉化、环糊精包合物、固体分散体,并详细介绍了结晶策略、离子液体、聚合物基、脂质基和无机基载体在提高溶解度和生物利用度方面的作用。文中介绍了一些最常用的已获批准的增溶技术载体材料,并总结了一些已获批准使用增溶技术的水溶性较差的药物。此外,本综述还详细介绍了每种增溶技术的增溶机制,回顾了最新的研究进展和挑战,并评估了临床转化的潜力。本综述可为水溶性差的药物选择增溶方法、剂型和给药途径提供指导。此外,我们还讨论了几种前景广阔的增溶技术,这些技术正吸引着全世界越来越多的关注。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
CiteScore
22.40
自引率
5.50%
发文量
1051
审稿时长
19 weeks
期刊介绍: The Journal of the Institute of Materia Medica, Chinese Academy of Medical Sciences, and the Chinese Pharmaceutical Association oversees the peer review process for Acta Pharmaceutica Sinica. B (APSB). Published monthly in English, APSB is dedicated to disseminating significant original research articles, rapid communications, and high-quality reviews that highlight recent advances across various pharmaceutical sciences domains. These encompass pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis, and pharmacokinetics. A part of the Acta Pharmaceutica Sinica series, established in 1953 and indexed in prominent databases like Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, and Current Bibliography on Science and Technology, APSB is sponsored by the Institute of Materia Medica, Chinese Academy of Medical Sciences, and the Chinese Pharmaceutical Association. Its production and hosting are facilitated by Elsevier B.V. This collaborative effort ensures APSB's commitment to delivering valuable contributions to the pharmaceutical sciences community.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信